Skip to main content
Clinical Trials/NCT03412175
NCT03412175
Completed
Not Applicable

CREATION Health Lifestyle Intervention

AdventHealth1 site in 1 country184 target enrollmentMay 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Risk
Sponsor
AdventHealth
Enrollment
184
Locations
1
Primary Endpoint
Hemoglobin A1C
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The CREATION Health Lifestyle Intervention (CHLI) will study the effect of a lifestyle intervention program on the cardiovascular risk profile (blood pressure, BMI, and Hemoglobin A1C) of participants diagnosed with hypertension and/or type 2 diabetes.

Detailed Description

The CREATION Health Lifestyle intervention is targeted at improving the cardiovascular risk profiles (blood pressure, BMI, and Hemoglobin A1C) of participants diagnosed with hypertension and/or type 2 diabetes. The intervention is designed to address the whole person and is based on the CREATION Health framework. Participants in the lifestyle intervention arm will receive 6 individual visits with a CREATION Health Specialist over a 3 month period, and one follow up visit at 6 months. The visits include one 2 hour-long initial assessment, four 60-minute motivational interview sessions, and two 60-minute reassessments. Visits will focus on tailoring the intervention care plan to each individual, goal-setting, action plans, self-monitoring, identification of personal and social barriers to change, self-regulatory techniques, and provision of psychosocial support using motivational interviewing techniques. Using the CREATION Health framework, the CREATION Health Specialist will educate the participant and make recommendations for lifestyle modifications that lead to reduction in cardiovascular disease risk by focusing on: reduced energy intake, primarily via lowering fat intake to \<30% of caloric intake; increased physical activity to 150 minutes per week; smoking cessation; limited sodium intake; and limited alcohol intake. Intervention fidelity will be determined by tracking the content of visits on encounter forms. There will also be a quality assurance assessment by audio-taping a select number of CHS-patient visits. The audiotapes will be reviewed by the study team and CHS for adherence to study intervention protocols. Participants in the intervention group will also receive a health journal to document progress and a CREATION Health workbook that introduces the CREATION Health framework in more detail. The workbook explains each concept of the CREATION Health framework: Choice; Rest; Environment; Activity; Trust in God; Interpersonal relationships; Outlook; and Nutrition. Participants in the intervention group will receive a CREATION Health One-sentence Journal.

Registry
clinicaltrials.gov
Start Date
May 2016
End Date
August 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of Type 2 Diabetes, fasting glucose \>125, or Hg A1C \>6.5% and/or
  • Diagnosis of Hypertension
  • Age 18 or older
  • Agree to participate in all aspects of study intervention and assessments
  • Able to give informed consent
  • Access to home phone or mobile phone

Exclusion Criteria

  • Current use of oral corticosteroids
  • Current use of psychotropics for psychosis or bipolar disorder
  • Use of weight-loss medication in the past 3 months
  • Psychiatric hospitalization in the past 3 years
  • Cancer diagnosis or treatment in the past 3 years
  • History of MI, CABG, stroke, PTCA, balloon pump, etc in past 2 years
  • Hemoglobin A1C 12% or more on two occasion in the past 6 months
  • Severe debilitating medical condition that would interfere with completion of intervention
  • Unable to speak, read, and understand English

Outcomes

Primary Outcomes

Hemoglobin A1C

Time Frame: 6 months

A reduction of Hemoglobin A1C in participants diagnosed with Type II Diabetes Mellitus to less than 6% as measured by fasting blood work

Blood Pressure

Time Frame: 6 months

A 6 mm Hg reduction in systolic blood pressure/diastolic blood pressure as measured in clinic in participants diagnosed with Hypertension

Study Sites (1)

Loading locations...

Similar Trials